Loss of ELF2 drives topotecan resistance in retinoblastoma revealed by genome-wide CRISPR-Cas9 screening
全基因组 CRISPR-Cas9 筛选揭示 ELF2 缺失驱动视网膜母细胞瘤产生拓扑替康耐药性
期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-025-08335-z.
Jingyi Jiang #,Zihua Jiang #,Qian Luo #,Xi Chen,Jiejie Zhuang,Jiaxin Chen,Qingqing Mu,Jin Qiu,Yan Li,Shuxia Chen,Ping Zhang,Keming Yu,Shuilian Chen,Guei-Sheung Liu,Jing Zhuang